C12N2770/24143 - CPC Classification Index

ClassID:

111322 ⎘

C12N2770/24143 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Flaviviridae; Flavivirus, e.g. yellow fever virus, dengue, JEV; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Recent Application in this class:

20260078403

2026-03-19

ZIKV-BASED GENE DELIVERY SYSTEM

20260053873

2026-02-26

COMBINATION THERAPY OF ONCOLYTIC VIRUS DRUGS FOR CANCER TREATMENT

20250171802

2025-05-29

NUCLEIC ACID COMPOSITIONS FOR DELIVERING EXOGENOUS POLYNUCLEOTIDES AND METHODS OF USE

20250154509

2025-05-15

ONCOLYTIC VIRUSES AND METHODS OF USE

20250057932

2025-02-20

VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RNA VIRUSES

20250018006

2025-01-16

Compositions and Methods for Dengue Virus Chimeric Constructions in Vaccines

20240424080

2024-12-26

Multi-Epitope Vaccine Platform

20240252619

2024-08-01

Coronavirus Constructs and Vaccines

20240226338

2024-07-11

Compositions For and Methods of Improving Gene Therapy

#10

20240131197

2024-04-25

Compositions For and Methods of Improving Gene Therapy

#11

20230181682

2023-06-15

Compositions and methods for dengue virus chimeric constructions in vaccines

#12

20220213504

2022-07-07

Zika Virus Constructs and Therapeutic Compositions Thereof

#13

20220062375

2022-03-03

Compositions and methods for dengue virus chimeric constructions in vaccines

#14

20210069317

2021-03-11

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

#15

20200316187

2020-10-08

Chimeric yellow fever ZIKA virus strain

#16

20200030435

2020-01-30

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

#17

20190374633

2019-12-12

Zika virus vaccines

#18

20190330591

2019-10-31

AMPLIFIABLE RNAS FOR THERAPEUTIC CELL SYSTEMS

#19

20190323034

2019-10-24

Compositions and methods for zika virus characterization and vaccine development

#20

20190314482

2019-10-17

Vaccines against infectious diseases caused by positive stranded RNA viruses

#21

20190175720

2019-06-13

ZIKA VIRUS VACCINE AND COMBINATION VACCINE

#22

20180369358

2018-12-27

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

#23

20180340011

2018-11-29

Flavivirus Vaccine

#24

20180036398

2018-02-08

Flavivirus replicons

#25

20170360916

2017-12-21

METHOD FOR THE PRODUCTION OF RECOMBINANT VIRUS, DNA CONSTRUCTS, RECOMBINANT VIRUS AND VACCINE COMPOSITIONS

#26

20170290884

2017-10-12

Compositions and methods for dengue virus chimeric constructs in vaccines

#27

20170196963

2017-07-13

Drug target and construct for Japanese encephalitis virus infection

#28

20170157237

2017-06-08

Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions

#29

20160367656

2016-12-22

Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions

#30

20150273035

2015-10-01

VACCINATION AGAINST JAPANESE ENCEPHALITIS, MEASLES, MUMPS AND RUBELLA

#31

20150024003

2015-01-22

Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions

#32

20140302088

2014-10-09

Compositions and methods for dengue virus chimeric constructs in vaccines

#33

20140294892

2014-10-02

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

#34

20130295134

2013-11-07

Recombinant bicistronic flavivirus vectors

#35

20130243809

2013-09-19

Recombinant flaviviral constructs and uses thereof

#36

20120321655

2012-12-20

LENTIVIRUS VACCINE BASED ON THE RECOMBINANT VIRAL VACCINE AGAINST YELLOW FEVER

#37

20120294889

2012-11-22

Chimeric Flavivirus Vaccines

#38

20120128713

2012-05-24

Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial Virus

#39

20120107358

2012-05-03

Subgenomic replicons of the flavivirus dengue

#40

20110311579

2011-12-22

Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof

#41

20110135686

2011-06-09

Replication-defective flavivirus vaccines and vaccine vectors

#42

20110135682

2011-06-09

Recombinant bicistronic flaviviruses and methods of use thereof

#43

20110014229

2011-01-20

Chimeric flavivirus vectors

#44

20110003884

2011-01-06

Viral Vectors and Methods of Use

#45

20100316670

2010-12-16

CHIMERIC SLE/DENGUE TYPE 4 ANTIGENIC VIRUSES

#46

20100297167

2010-11-25

Method for the production of recombinant virus, DNA constructs, recombinant virus and vaccine compositions

#47

20100278773

2010-11-04

Chimeric flavivirus vaccines

#48

20100255028

2010-10-07

Flavivirus vaccine vector against influenza virus

#49

20100233210

2010-09-16

Subgenomic replicons of the flavivirus dengue

#50

20100221282

2010-09-02

Recombinant vaccine against West Nile Virus

#51

20100184832

2010-07-22

Construction of Recombinant Virus Vaccines by Direct Transposon-Mediated Insertion of Foreign Immunologic Determinants into Vector Virus Proteins

#52

20100034849

2010-02-11

Recombinant bicistronic vectors

#53

20090324623

2009-12-31

Two-component genome flavivirus and uses thereof

#54

20080188640

2008-08-07

Immunodeficiency recombinant poxvirus

#55

20080152633

2008-06-26

Flavivirus Replicon Constructs for Tumor Therapy

#56

20070249032

2007-10-25

Flavivirus vaccine

#57

20060204523

2006-09-14

Flavivirus vaccine delivery system

#58

20060159704

2006-07-20

Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents

#59